New RealWorld Analyses Support Effectiveness and Safety of Entyvio vedolizumab for Ulcerative Colitis and Crohn's Disease

OSAKA Japan May 8 2017 PRNewswire Takeda Pharmaceutical Company Limited TSE 4502 "Takeda" today announced the presentation of eight realworld analyses supporting the effectiveness and safety of Entyvio vedolizumab for the treatment of adults wi...